DDIIX
Price
$16.13
Change
-$0.02 (-0.12%)
Updated
Oct 6 closing price
Net Assets
847.45M
RLBGX
Price
$39.06
Change
+$0.07 (+0.18%)
Updated
Oct 6 closing price
Net Assets
265.73B
Interact to see
Advertisement

DDIIX vs RLBGX

Header iconDDIIX vs RLBGX Comparison
Open Charts DDIIX vs RLBGXBanner chart's image
Macquarie Wealth Builder Institutional
Price$16.13
Change-$0.02 (-0.12%)
VolumeN/A
Net Assets847.45M
American Funds American Balanced R6
Price$39.06
Change+$0.07 (+0.18%)
VolumeN/A
Net Assets265.73B
DDIIX vs RLBGX Comparison Chart in %
View a ticker or compare two or three
VS
DDIIX vs. RLBGX commentary
Oct 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DDIIX is a Buy and RLBGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBGX has more cash in the bank: 266B vs. DDIIX (847M). RLBGX pays higher dividends than DDIIX: RLBGX (2.05) vs DDIIX (1.74). DDIIX was incepted earlier than RLBGX: DDIIX (29 years) vs RLBGX (16 years). DDIIX (0.84) is less costly to investors than RLBGX (0.25). DDIIX is a more actively managed with annual turnover of: 66.00 vs. RLBGX (44.00). DDIIX has a lower initial minimum investment than RLBGX: DDIIX (0) vs RLBGX (250). RLBGX annual gain was more profitable for investors over the last year : 10.01 vs. DDIIX (5.54). RLBGX return over 5 years is better than : 45.71 vs. DDIIX (34.97).
DDIIXRLBGXDDIIX / RLBGX
Total Expense Ratio0.810.25324%
Annual Report Gross Expense Ratio0.840.25336%
Fund Existence29 years16 years-
Gain YTD11.29615.01075%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets847M266B0%
Annual Yield % from dividends1.742.0585%
Returns for 1 year5.5410.0155%
Returns for 3 years30.1752.9957%
Returns for 5 years34.9745.7176%
Returns for 10 years46.4180.8857%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SKE18.140.68
+3.89%
Skeena Resources Limited
ISRL13.000.30
+2.39%
Israel Acquisitions Corp
PACB1.520.03
+2.01%
Pacific Biosciences of California
AKAM78.440.88
+1.13%
Akamai Technologies
NIVF1.75-0.09
-4.89%
NewGenIvf Group Limited